The impact of human immunodeficiency virus (HIV) infection on Mycobacterium
kansasii disease in miners was investigated with a retrospective study cov
ering a single workforce. M. kansasii, isolated from 43 HIV-positive and 20
2 HIV-negative miners, was the most common nontuberculous mycobacterial (NT
M) species in both HIV groups. CD4 counts were unusually high for M. kansas
ii disease (mean 490 x 10(6)/L, from 14 HIV-positive men). Treatment outcom
es were similar: mortality during treatment was higher in HIV-positive than
in HIV-negative men (9% and 2%, respectively), but not significantly so. T
he majority of a sample of 31 HIV-positive and 92 HIV-negative men had radi
ological silicosis and/or old tuberculosis scarring prior to M. kansasii di
sease. A normal premorbid radiograph was more common in HIV-positive men (4
5% versus 24%; odds ratio [OR], 2.62; 95% confidence interval [95% CI], 1.0
1 to 6.67). New cavitation was less common (55% versus 78%; OR, 0.34; 95% C
I, 0.13 to 0.88) and new hilar adenopathy more common (OR, 5.07; 95% CI, 1.
24 to 21.9) in HIV-positive than in HIV-negative men. Miners, who have addi
tional NTM risk factors, develop M. kansasii disease that occurs at an earl
ier stage of HIV infection and more closely resembles disease in HIV-negati
ve men than has been found for HIV-associated M. kansasii disease in other
settings.